# Apple Hospitality REIT, Inc.: financial statements, quarterly APLE · NYSE · CIK 1418121 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/aple.md) · [Financials](/companies/aple/financials.md) · [Filings](/companies/aple/filings.md) · [Insiders](/companies/aple/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aple/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [358](/filings/0000950170-24-120709.md) | [312 d](/filings/0001193125-26-064008.md) | [330](/filings/0000950170-25-061853.md) | [390](/filings/0000950170-25-104057.md) | [379](/filings/0001193125-25-262579.md) | [333 d](/filings/0001193125-26-064008.md) | [328](/filings/0001193125-26-204023.md) | [384](/filings/0001193125-26-335151.md) | [374](/filings/0001193125-25-262579.md) | [326 d](/filings/0001193125-26-064008.md) | [338](/filings/0001193125-26-204023.md) | [403](/filings/0001193125-26-335151.md) | | Cost of revenue | $m | [204](/filings/0000950170-24-120709.md) | [191 d](/filings/0001193125-26-064008.md) | [197](/filings/0000950170-25-061853.md) | [216](/filings/0000950170-25-104057.md) | [220](/filings/0001193125-25-262579.md) | [204 d](/filings/0001193125-26-064008.md) | [200](/filings/0001193125-26-204023.md) | [221](/filings/0001193125-26-335151.md) | [222](/filings/0001193125-25-262579.md) | [205 d](/filings/0001193125-26-064008.md) | [207](/filings/0001193125-26-204023.md) | [228](/filings/0001193125-26-335151.md) | | Operating income | $m | [76.3](/filings/0000950170-24-120709.md) | [38.9 d](/filings/0001193125-26-064008.md) | [71.6](/filings/0000950170-25-061853.md) | [93.5](/filings/0000950170-25-104057.md) | [77.7](/filings/0001193125-25-262579.md) | [49.9 d](/filings/0001193125-26-064008.md) | [50.9](/filings/0001193125-26-204023.md) | [84.9](/filings/0001193125-26-335151.md) | [72.5](/filings/0001193125-25-262579.md) | [49.6 d](/filings/0001193125-26-064008.md) | [48.0](/filings/0001193125-26-204023.md) | [88.2](/filings/0001193125-26-335151.md) | | Income tax | $m | [0.3](/filings/0000950170-24-120709.md) | [0.3 d](/filings/0001193125-26-064008.md) | [0.3](/filings/0000950170-25-061853.md) | [0.2](/filings/0000950170-25-104057.md) | [0.2](/filings/0001193125-25-262579.md) | [0.2 d](/filings/0001193125-26-064008.md) | [0.2](/filings/0001193125-26-204023.md) | [0.2](/filings/0001193125-26-335151.md) | [0.2](/filings/0001193125-25-262579.md) | [0.2 d](/filings/0001193125-26-064008.md) | [0.2](/filings/0001193125-26-204023.md) | [0.3](/filings/0001193125-26-335151.md) | | Net income | $m | [58.5](/filings/0000950170-24-120709.md) | [20.8 d](/filings/0001193125-26-064008.md) | [54.1](/filings/0000950170-25-061853.md) | [73.9](/filings/0000950170-25-104057.md) | [56.3](/filings/0001193125-25-262579.md) | [29.8 d](/filings/0001193125-26-064008.md) | [31.2](/filings/0001193125-26-204023.md) | [63.6](/filings/0001193125-26-335151.md) | [50.9](/filings/0001193125-25-262579.md) | [29.6 d](/filings/0001193125-26-064008.md) | [27.7](/filings/0001193125-26-204023.md) | [67.1](/filings/0001193125-26-335151.md) | | Diluted EPS | $ per share | [0.26](/filings/0000950170-24-120709.md) | not reported | [0.22](/filings/0000950170-25-061853.md) | [0.31](/filings/0000950170-25-104057.md) | [0.23](/filings/0001193125-25-262579.md) | not reported | [0.13](/filings/0001193125-26-204023.md) | [0.27](/filings/0001193125-26-335151.md) | [0.21](/filings/0001193125-25-262579.md) | not reported | [0.12](/filings/0001193125-26-204023.md) | [0.28](/filings/0001193125-26-335151.md) | | Basic EPS | $ per share | [0.26](/filings/0000950170-24-120709.md) | not reported | [0.22](/filings/0000950170-25-061853.md) | [0.31](/filings/0000950170-25-104057.md) | [0.23](/filings/0001193125-25-262579.md) | not reported | [0.13](/filings/0001193125-26-204023.md) | [0.27](/filings/0001193125-26-335151.md) | [0.21](/filings/0001193125-25-262579.md) | not reported | [0.12](/filings/0001193125-26-204023.md) | [0.28](/filings/0001193125-26-335151.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [35.4](/filings/0000950170-24-120709.md) | [10.3](/filings/0001193125-26-064008.md) | [4.9](/filings/0000950170-25-061853.md) | [7.2](/filings/0000950170-25-104057.md) | [6.1](/filings/0001193125-25-262579.md) | [10.3](/filings/0001193125-26-335151.md) | [14.9](/filings/0001193125-26-204023.md) | [7.9](/filings/0001193125-26-335151.md) | [50.3](/filings/0001193125-25-262579.md) | [8.5](/filings/0001193125-26-335151.md) | [7.8](/filings/0001193125-26-204023.md) | [10.2](/filings/0001193125-26-335151.md) | | Total assets | $m | [4,764](/filings/0000950170-23-060274.md) | [4,937](/filings/0000950170-25-025638.md) | [5,032](/filings/0000950170-24-053569.md) | [5,075](/filings/0000950170-24-090771.md) | [5,022](/filings/0000950170-24-120709.md) | [4,970](/filings/0001193125-26-064008.md) | [4,948](/filings/0000950170-25-061853.md) | [4,929](/filings/0000950170-25-104057.md) | [4,914](/filings/0001193125-25-262579.md) | [4,902](/filings/0001193125-26-335151.md) | [4,894](/filings/0001193125-26-204023.md) | [4,865](/filings/0001193125-26-335151.md) | | Total liabilities | $m | [1,590](/filings/0000950170-23-060274.md) | [1,613](/filings/0000950170-25-025638.md) | [1,698](/filings/0000950170-24-053569.md) | [1,742](/filings/0000950170-24-090771.md) | [1,725](/filings/0000950170-24-120709.md) | [1,704](/filings/0001193125-26-064008.md) | [1,735](/filings/0000950170-25-061853.md) | [1,730](/filings/0000950170-25-104057.md) | [1,724](/filings/0001193125-25-262579.md) | [1,754](/filings/0001193125-26-335151.md) | [1,768](/filings/0001193125-26-204023.md) | [1,724](/filings/0001193125-26-335151.md) | | Long-term debt | $m | [1,373](/filings/0000950170-23-060274.md) | [1,371](/filings/0000950170-25-025638.md) | [1,501](/filings/0000950170-24-053569.md) | [1,537](/filings/0000950170-24-090771.md) | [1,501](/filings/0000950170-24-120709.md) | [1,471](/filings/0001193125-26-064008.md) | [1,535](/filings/0000950170-25-061853.md) | [1,526](/filings/0000950170-25-104057.md) | [1,508](/filings/0001193125-25-262579.md) | [1,539](/filings/0001193125-26-335151.md) | [1,566](/filings/0001193125-26-204023.md) | [1,502](/filings/0001193125-26-335151.md) | | Shareholders' equity | $m | [3,174](/filings/0000950170-24-120709.md) | [3,324](/filings/0001193125-26-064008.md) | [3,334](/filings/0000950170-25-104057.md) | [3,333](/filings/0001193125-25-262579.md) | [3,297](/filings/0001193125-25-262579.md) | [3,266](/filings/0001193125-26-335151.md) | [3,213](/filings/0001193125-26-335151.md) | [3,199](/filings/0001193125-26-335151.md) | [3,190](/filings/0001193125-25-262579.md) | [3,149](/filings/0001193125-26-335151.md) | [3,127](/filings/0001193125-26-335151.md) | [3,141](/filings/0001193125-26-335151.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Total assets: us-gaap:Assets - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [132 d](/filings/0000950170-24-120709.md) | [96.9 d](/filings/0001193125-26-064008.md) | [54.7](/filings/0000950170-25-061853.md) | [127 d](/filings/0000950170-25-104057.md) | [128 d](/filings/0001193125-25-262579.md) | [95.2 d](/filings/0001193125-26-064008.md) | [49.1](/filings/0001193125-26-204023.md) | [109 d](/filings/0001193125-26-335151.md) | [126 d](/filings/0001193125-25-262579.md) | [85.8 d](/filings/0001193125-26-064008.md) | [48.9](/filings/0001193125-26-204023.md) | [125 d](/filings/0001193125-26-335151.md) | | Capital expenditure | $m | not reported | not reported | [20.3](/filings/0000950170-25-061853.md) | [12.3 d](/filings/0000950170-25-104057.md) | [15.1 d](/filings/0001193125-25-262579.md) | [30.6 d](/filings/0001193125-26-064008.md) | [19.6](/filings/0001193125-26-204023.md) | [12.6 d](/filings/0001193125-26-335151.md) | [17.4 d](/filings/0001193125-25-262579.md) | [38.6 d](/filings/0001193125-26-064008.md) | [27.5](/filings/0001193125-26-204023.md) | [12.3 d](/filings/0001193125-26-335151.md) | | Dividends paid | $m | [54.8](/filings/0000950170-24-120709.md) | [55.2 d](/filings/0001193125-26-064008.md) | [70.2](/filings/0000950170-25-061853.md) | [58.0](/filings/0000950170-25-104057.md) | [57.7](/filings/0001193125-25-262579.md) | [57.8 d](/filings/0001193125-26-064008.md) | [69.6](/filings/0001193125-26-204023.md) | [57.1](/filings/0001193125-26-335151.md) | [56.8](/filings/0001193125-25-262579.md) | [56.9 d](/filings/0001193125-26-064008.md) | [56.6](/filings/0001193125-26-204023.md) | [56.6](/filings/0001193125-26-335151.md) | | Share repurchases | $m | [0.0 d](/filings/0000950170-24-120709.md) | [0.0 d](/filings/0001193125-26-064008.md) | [0.0](/filings/0000950170-25-061853.md) | [15.5 d](/filings/0000950170-25-104057.md) | [19.2 d](/filings/0001193125-25-262579.md) | [0.0 d](/filings/0001193125-26-064008.md) | [26.3](/filings/0001193125-26-204023.md) | [16.9 d](/filings/0001193125-26-335151.md) | [2.0 d](/filings/0001193125-25-262579.md) | [13.1 d](/filings/0001193125-26-064008.md) | [0.0](/filings/0001193125-26-204023.md) | [0.0 d](/filings/0001193125-26-335151.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [229](/filings/0000950170-23-060274.md) | [229](/filings/0000950170-24-053569.md) | [229](/filings/0000950170-24-090771.md) | [229](/filings/0000950170-24-120709.md) | [242](/filings/0000950170-25-061853.md) | [242](/filings/0000950170-25-104057.md) | [241](/filings/0001193125-25-262579.md) | [240](/filings/0001193125-26-204023.md) | [238](/filings/0001193125-26-335151.md) | [237](/filings/0001193125-25-262579.md) | [236](/filings/0001193125-26-204023.md) | [236](/filings/0001193125-26-335151.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 236,082,698 at 2026-07-27, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-335151.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.